Onoe Satoru, Temma Takashi, Shimizu Yoichi, Ono Masahiro, Saji Hideo
Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Cancer Med. 2014 Aug;3(4):775-86. doi: 10.1002/cam4.252. Epub 2014 Apr 16.
Mitochondrial membrane potential (Δψm ) alteration is an important target for cancer diagnosis. In this study, we designed a series of near-infrared fluorescent cationic cyanine dyes with varying alkyl chain lengths (IC7-1 derivatives) to provide diverse lipophilicities and serum albumin-binding rates, and we evaluated the usefulness of these derivatives for in vivo Δψm imaging. IC7-1 derivatives with side chains from methyl to hexyl (IC7-1-Me to IC7-1-He) were synthesized, and their optical properties were measured. Cellular uptake and intracellular distribution were investigated with depolarized HeLa cells from carbonyl cyanine m-chlorophenylhydrazone (CCCP) treatment using a spectrofluorometer and a fluorescence microscope. Serum albumin-binding rates were evaluated using albumin-binding inhibitors. In vivo optical imaging was performed with HeLa cell xenograft mice following intravenous administration of IC7-1 derivatives with or without warfarin and CCCP as in vivo blocking agents. IC7-1 derivatives showing maximum excitation and emission wavelengths at 823 nm and ~845 nm, respectively, were synthesized. IC7-1-Me to -Bu showed fluorescence in mitochondria that decreased with CCCP treatment in a concentration-dependent manner, which showed that IC7-1-Me to -Bu successfully indicated Δψm . Tumors were clearly visualized after IC7-1-Bu administration. Treatment with warfarin or CCCP significantly decreased IC7-1-Bu fluorescence in the tumor region. In summary, IC7-1-Bu exhibited fluorescence localized to mitochondria dependent on Δψm , which enabled clear in vivo tumor imaging via serum albumin as a drug carrier for effective tumor targeting. Our data suggest that IC7-1-Bu is a promising NIR probe for in vivo imaging of the altered Δψm of tumor cells.
线粒体膜电位(Δψm)改变是癌症诊断的一个重要靶点。在本研究中,我们设计了一系列具有不同烷基链长度的近红外荧光阳离子花青染料(IC7-1衍生物),以提供不同的亲脂性和血清白蛋白结合率,并评估这些衍生物用于体内Δψm成像的效用。合成了侧链从甲基到己基的IC7-1衍生物(IC7-1-Me至IC7-1-He),并测量了它们的光学性质。使用分光荧光计和荧光显微镜,对经羰基氰化物间氯苯腙(CCCP)处理的去极化HeLa细胞进行细胞摄取和细胞内分布研究。使用白蛋白结合抑制剂评估血清白蛋白结合率。在静脉注射IC7-1衍生物(有或没有华法林和CCCP作为体内阻断剂)后,对HeLa细胞异种移植小鼠进行体内光学成像。合成了分别在823nm和~845nm处显示最大激发和发射波长的IC7-1衍生物。IC7-1-Me至-Bu在线粒体中显示荧光,其随着CCCP处理呈浓度依赖性降低,这表明IC7-1-Me至-Bu成功指示了Δψm。注射IC7-1-Bu后肿瘤清晰可见。用华法林或CCCP处理显著降低了肿瘤区域的IC7-1-Bu荧光。总之,IC7-1-Bu表现出依赖于Δψm定位于线粒体的荧光,这使得通过血清白蛋白作为有效肿瘤靶向的药物载体能够在体内进行清晰肿瘤成像。我们的数据表明,IC7-1-Bu是一种用于体内成像肿瘤细胞改变的Δψm很有前景的近红外探针。